Aimei Health Technology Co Ltd

Research Aimei Health Technology Co Ltd (AFJK) on Bullrun: market cap USD 38.88M, P/E 176.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 38.88M; P/E is 176.9.

Peer valuation comparison

Latest P/E is 176.95x versus a Financial Services sector median of 13.84x (1178.8% above).

Latest P/E is 176.95x versus a United States median of 24.87x (611.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0USD 1.06M-USD 1.09Mn/a0.33USD 2.93KUSD 2.02M-USD 4.06M
FY2024USD 0USD 2.55M-USD 672.29Kn/a0.51USD 28.21KUSD 227.70K-USD 1.48M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 38.88M176.9n/an/a
20252025-12-31USD 391.85M320.1n/an/a
20242024-12-31USD 96.58M38.2n/an/a

About Aimei Health Technology Co Ltd

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is Aimei Health Technology Co Ltd's market cap?

Aimei Health Technology Co Ltd's market capitalization is USD 38.88M.

What is Aimei Health Technology Co Ltd's P/E ratio?

Aimei Health Technology Co Ltd's price-to-earnings (P/E) ratio is 176.9.

What does Aimei Health Technology Co Ltd do?

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.